Ventana Medical Systems
Michael Herman is a seasoned scientist currently working at Roche since December 2004, where the role includes Project Manager in the Research Use Only group focused on new product launches. Previous positions at Roche involved coordinating updates to FDA-regulated Quality Systems documents, overseeing design transfer from Product Development to Manufacturing Operations, and manufacturing and purifying bioconjugates. Earlier experience includes working as a Research Associate at Discovery Partners, International, where responsibilities encompassed high throughput purification and analysis of drug-discovery libraries and medium-scale synthesis of pharmaceutical precursors. Michael holds a B.S. in Chemistry from the University of Arizona, earned in 2000.
Ventana Medical Systems
Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.